Who boasts the biggest overseas cash coffers? Amgen and Gilead, to name a couple
FiercePharma | May 01, 2017
At January’s JPMorgan Healthcare Conference, Amgen CEO Robert Bradway proclaimed that his company would be “a clear beneficiary” of any corporate tax reform U.S. President Donald Trump could enact.